MMP9 and endometrial cancer: The analysis of NGAL/MMP-9 indicator in patients with endometrial cancer as compared to patients with benign endometrium changes was statistically significant differences between the compared groups—64.7 pg/mL/44.4 pg/mL (p = 0.001).